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Abstract
Parkinson’s disease is a common neurodegenerative disorder. It is associated with the
central nervous system that affects movement, it often includes tremors, stiffness, and inability to
plan and think. Nerve cell damage in the brain causes lower production of dopamine leading to
those symptoms. There is no cure for Parkinson’s disease, but there are medications that can help
control the symptoms. Researchers are suggesting that dysbiosis in gut microbiota could lead to
the development of a protein called alpha synuclein in the intestines, and through intestinal
leakage, this protein could possibly spread pathologically to the brain by the central nervous
system. This protein then folds and forms a clump blocking dopamine production and then
causing symptoms of Parkinson’s disease. What causes this protein to fold is still unknown.
This review focuses specifically on what factors may be contributing to Parkinson’s disease, the
effects gut microbiota has on Parkinson’s disease, and how the alpha synuclein protein plays an
important role in Parkinson’s disease. With all information found, dysbiosis of the intestines
cannot be concluded to be the cause of Parkinson’s disease.
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Introduction
Parkinson’s disease is a neurodegenerative disorder that affects dopamine producing
neurons in a specific area of the brain that is called substantia nigra. The substantia nigra is
located in the midbrain and plays an important role in movement, reward, and addiction. Its
function is to control dopamine production and it consist of two parts, the pars compacta and
pars reticulata. The pars compacta contain neurons colored in black by pigment neuromelanin,
and the pars reticulata is where the dendrites function. In Parkinson’s patients, the substantia
nigra will cause balance problems, tremors, limb rigidity, and thinking/solving problems.
Although this disease is not fatal, it is serious and has serious effects on the quality of life.
About 7 to 10 million people worldwide live with Parkinson’s diseases and about 4 percent of
people with Parkinson’s disease are diagnosed before the age of 50. Men are 1.5 times more
likely to get Parkinson’s disease than women. In the U.S alone, the overall cost of Parkinson’s
disease including treatments, loss of income, and social security are estimated to be $25 billion
per year (parkinsons.org). However, despite the research that has been done on Parkinson’s, the
cause is still unknown. Microbes in the gut microbiota have impacts on how disease will affect
the body. In this study, there will be a focus on the effects of unbalanced gut microbiota on
Parkinson’s disease. This is significant because knowing exactly what links gut microbiota and
Parkinson’s diseases share could possibly predict how likely one is susceptible to the disease.
This review will focus on exploring the microbiota in patients with Parkinson’s vs patients
without Parkinson’s, the proteins that are associated with Parkinson’s, and how dysbiosis of the
gut along with the proteins effect brain stimulation.
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Understanding What Parkinson’s Disease is and the Associations of Parkinson’s
Disease
Parkinson’s disease is a neurological disorder that affects the motor system. Dopamine is
a chemical transmitter that allows nerve cells to send signals within the brain that allows us to
control our movements. In a normal human brain, cells produce dopamine that pass signals
within the brain to produce a movement of a muscle in a smooth form. In Parkinson’s patients,
80 percent, and sometimes even more of the cells that produce dopamine are either dead,
damaged or somehow degenerated. This will cause the cells to fire uncontrollably within the
brain not allowing patients to control their movements. Symptoms of this would-be things such
as tremors in the legs, arms, and hands. Also, stiffness, impaired coordination, balance problems,
and slowness of movements.
Research done in Parkinson’s disease has found that genetics plays a big role in this disease.
There are five genes that are thought to play a role in this disease, Parkin, SCA2, Alpha
synuclein, Ubiquitin carboxyl-terminal hydrolase, and DJ-1. Within these genes, it is their
mutations which have been found to be the underlying cause (Gerhard, 2018). Researchers
believe that environmental factors act on these specific genes which then lead to Parkinson’s
disease. If this mechanism can be figured out, we could possibly then disrupt it and stop it from
leading to Parkinson’s disease. One of the environmental factors and/or mechanisms researchers
think it may be is the link of gut microbiota and the brain of Parkinson’s disease patients.
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The Dysbiosis of Gut Microbiota
Dysbiosis of the gut is a term used to describe the microbial imbalance of the human intestines.
The human gut contains trillions of microorganisms of which include more than 1000 different
species of bacteria. While we all have our own unique structure of microbiota, it physiologically
impacts our health in the same ways. The gut microbiota is a composed community of
microorganism inhibiting the gastrointestinal track. The composition of the microbes is host
specific. Mammals gut microbiota can undergo alterations, all mammals are born with a sterile
gastrointestinal tract and then are developed within the first years of life. In the first year of life
especially, the gut microbiota will change through interactions with the developing immune
system. Different environmental factors will also determine the composition of the gut
microbiota and will have a potential to be a main determiner in life long health. The balance of
gut microbiota can be affected as we age and the imbalance of microbiota is something we call
dysbiosis. Dysbiosis can be linked to many health problems such as bowel disease, obesity, and
now even Parkinson’s disease. Differences in the gut microbiota can result in changes of
substances within the gut and intestinal permeability which can influence the central nervous
system.
It has been considered that bacteria can enhance inflammatory response and that the imbalance
of gut dysbiosis can disrupt the blood-brain barrier and increase neuro-inflammation. (Jankovic,
2018). It has been shown that many Parkinson’s patients have a reduced number of
Prevotellaceae family and an increased number of Enterobacteriaceae. The shift associated with
these two bacterial families shows a decrease in mucin synthesis and increase in intestinal
permeability, this is consistent with inflammatory pathways and protein miss-folding (Jankovic,
2018). Gut bacteria are able to control the differentiation and function of the immune cells in the
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intestine and brain. Typically, patients with Parkinson’s disease experience intestinal
inflammation such as constipation and many years later is followed by motor defects.

What Different Factors Affect the Composition of Gut Microbiota
In a conducted case study (Keshavarzian, 2011) there were 13 taxa, 8 genera, and 7 families that
were associated with Parkinson’s disease. A few of those were only potentially confounded, but
most were robust. Deletion of chain fatty acids in Parkinson’s disease was also found. Chain
fatty acids are made by bacteria in the gut, such as Lachnospiraceae. Lachnospiraceae was
shown to have reduced levels in those patients with Parkinson’s disease (Jankovic, 2018). This is
suggesting Parkinson’s patients have unbalanced dysbiosis of the gut.
This study (Keshavarzian, 2011) also suggests that there may be an increase in activity of
Parkinson’s in pathways that degrade xenobiotics (substances foreign to the body), atrazine
(herbicide), and a few others. According to the U.S Environmental Protection Agency, atrazine is
the most common herbicide contaminant in ground water found here in America. This is
important because exposure to this herbicide by drinking water or by elsewhere is known to
increase the risk of developing Parkinson’s disease in animal models. This suggest that
herbicides could also play a role in gut microbiota. If atrazine found in ground water that people
drink is known to increase the risk of developing Parkinson’s in animal models, then it should be
a serious concern for humans as well.
A study conducted (Gerhard, 2018) used gut bacteria from Parkinson’s patients and healthy
controls to transplant fecal matter into genetically susceptible mice. The mice with gut bacteria
from the Parkinson’s patient revealed enhanced motor impairment compared to the microbiota
6

from the healthy controls. This suggests that certain microbes from the Parkinson’s patients
holds disease-like symptoms unlike the healthy controls that were used.

Possible Causes of Dysbiosis
Supporting evidence suggests that there is a link between dysbiosis of gut microbiota and
Parkinson’s disease. But what is the cause of dysbiosis? Epidemiological evidence shows
pesticide exposure to Parkinson’s disease with some specific pesticides being known to impact
gut microbiota. Parkinson’s patients may be missing or have a reduced number of protective
microbes in their microbiota causing dysbiosis to result in differential production of microbial
molecules (Keshavarzian, 2011).
Other researchers propose that physical and psychological stress, dietary factors, and antibiotics
all contribute to intestinal dysbiosis. A study conducted shows that exposure to psychological
stress results in lower production of mucin and acidic mucopolysaccharides on the mucosal
surface of the intestines. Because mucopolysaccharides and mucin are both needed for inhibiting
adherence of pathogenic microorganisms to intestines mucosa, a decrease in either will
contribute to colonization by pathogenic microorganisms (Hawrelak, 2004). A well-balanced diet
will benefit people by assisting with the growth of more beneficial microorganisms, while some
other diets with assist gut microbiota activity that can be harmful to the host. Lastly, antibiotics
are the most significant cause of dysbiosis of the intestines. Antimicrobial agents will influence
dysbiosis of the intestine by its spectrum of activity, dosage and length of time taken. Depending
on all of these factors will tell how much dysbiosis is happening and how dysbiosis starts
affecting molecules and gut barriers (Hawrelak, 2004).
7

When dysbiosis has occurred, molecules start getting altered and the functions of gut barriers and
intestinal permeability changes. The rearranged microbiota products inside the intestines, such as
proteins may leave the intestines and travel to brain via central nervous system. Alpha synuclein,
a protein that is a neuropathological hallmark of Parkinson’s disease may appear in the gut
before it appears in the brain because of dysbiosis. These observations may have led to the
assumptions that Parkinson’s disease starts in the gut and then spreads to the brain by a leaky gut
membrane (Pereira, 2018).

Effects of Increased Intestinal Permeability
Intestinal permeability is a term used to describe the ability of substances such as bacteria
and proteins to pass through the gut and into the body by cells that line the gut wall. Once
substances are released through the gut they can travel to the brain by the central nervous system.
A study conducted (Forsyth, 2011) tested to see if Parkinson’s patients show increased intestinal
permeability to microbes in the intestines. This was done by assessing the permeability of the gut
with Parkinson’s patients and healthy controls. Intestinal biopsies of both groups were taken and
the bacterial translocation and the protein alpha synuclein were both observed. Intestinal hyper
permeability was found to significantly correlate with E. coli bacteria and alpha synuclein
protein in the Parkinson’s patients. This suggests that the Parkinson’s patients do in fact have a
leaky gut barrier compared to the healthy controls who did not. Once the gut starts leaking
materials, they can enter into the blood stream and cause widespread inflammation. They can
also travel to the brain by the central nervous system.
8

Folding of Alpha Synuclein Protein
Other research on gut microbiota and the association of Parkinson’s disease show from
conducted studies (Jankovic, 2018) of fecal samples taken within the duration of two years or
less, that the count of bacteria is different with Parkinson’s patients and heathy controls, but the
type of bacteria specifically is almost the same. There were no different bacteria found that were
typically more present in one of the study groups. This is suggesting that the type of bacteria
present within the intestines is not as relevant as the balance that allows enough good bacteria to
remain present.
Typically, in previous studies, the healthy controls and the Parkinson’s patient’s intestinal
bacteria type remained pretty much the same. It was the count that was higher or lower within
the two groups that was different, with Parkinson’s patients having more dysbiosis then the
healthy controls. What seems to be present in most case studies is the alpha synuclein protein in
association with intestinal permeability. Alpha synuclein is a protein found in the human body.
Within the brain, it is specifically found at the end of nerve cells (those which send signals
throughout the brain allowing movement) which are responsible for releasing chemicals such a
dopamine. Dopamine is the neurotransmitter that is involved with the control of voluntary and
involuntary movements. These alpha synuclein proteins in a Parkinson’s patients are
hypothesized to form and leak out of the intestines because of dysbiosis and intestinal
permeability, travel up to the brain via central nervous system, and form a sort of clump that is
toxic at the end of nerve cells that release dopamine. This folded alpha synuclein protein will
block the ability of dopamine to release and can even lead to cell death. Because dopamine is
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unable to release, patients with Parkinson’s cannot control voluntary and involuntary movements
with the blockage of this protein inside the brain. What causes this protein to fold and is still
unknown and is being studied.

Promoting Good Intestinal Health
Making sure there is not increase in intestinal permeability is more crucial than people may
think. Leaky gut walls are usually caused by the type of diet that one is consuming. Diets that
consume of a lot of grain, wheat, sugar, processed meats, and oils are those more susceptible to
have increase intestinal permeability (healthline.com). Other factors play a role in increased
intestinal permeability also, such as nonsteroidal anti-inflammatory drugs which include
Acetaminophen, Tylenol, and Ibuprofen. Taking rounds of antibiotics and chronically being
stressed has also been known to cause leaky intestines.
Symptoms of increased intestinal permeability may be constipation, diarrhea, bloating, excessive
burping and gas, migraines, weight gain, autoimmune conditions, fatigue and food allergies
(healthline.com). There is testing that can be done to determine if one is having increased
intestinal permeability. Those tests would include bacterial dysbiosis test, blood tests checking
for IgG and IgA antibodies produced by the immune system, a comprehensive stool and
digestive analysis test (healthline.com). Increased intestinal permeability develops slowly over
years, and healing the gut also takes time. It can take anywhere from three months to a year by
eating healthier, taking probiotics, and keeping stress levels under control to repair a leaky gut.
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Conclusion
While we all have our own unique structure of microbiota, it physiologically impacts our
health in the same ways. The balance of our gut microbiota can be affected as we age by diet,
drug consumption, environmental factors, and even our genetics. The imbalance of our
microbiota can have consequences to our health. The research done on gut microbiota with the
association of Parkinson’s disease shows almost always that the count of bacteria is different
with Parkinson’s patients vs heathy controls, but the type of bacteria found between the two
groups is typically the same. While it is unsure if increased intestinal permeability from
microbiota causes Parkinson’s disease, it is hypothesized that dysbiosis in the intestine might be
the reason for neuro-inflammation that leads to the alpha synuclein protein folding in patients
with Parkinson’s. What causes this protein to fold and clump is still unknown. Research is
suggesting it may start in the dysbiosis of the intestines and then lead to the development of
intestinal alpha synuclein, and through increased intestinal permeability, it pathologically spreads
to the brain and folds. Because of this protein folding, nerve cells that send signals throughout
the brain by releasing chemicals like dopamine are interrupted by the folding of the toxic protein.
This follows by the symptoms of Parkinson’s disease, such as tremors, stiffness, imbalance, and
ability to plan and think. In conclusion, this review found out that increased intestinal
permeability may be the cause of the alpha synuclein protein leaking out of the gut and spreading
to the brain by the central nervous system. This review also found that dysbiosis of the gut could
be where the start of Parkinson’s disease occurs many years before diagnosis. Lastly, this review
found that alpha synuclein plays a very important role in contributing to Parkinson’s disease
because it blocks dopamine production by folding. With all information found, dysbiosis cannot
be concluded to be the cause of Parkinson’s disease. As there is no cure for Parkinson’s disease,
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managing the microbiota would be the most helpful thing to do, yet also very challenging.
Although a good diet may decrease intestinal permeability, there is no control over genetics,
environmental factors, pathogens, antibiotics, and immunity.
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